153 related articles for article (PubMed ID: 29221110)
21. miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer.
Gao J; Li N; Dong Y; Li S; Xu L; Li X; Li Y; Li Z; Ng SS; Sung JJ; Shen L; Yu J
Oncogene; 2015 Jul; 34(31):4142-52. PubMed ID: 25362853
[TBL] [Abstract][Full Text] [Related]
22. ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis.
Agesen TH; Sveen A; Merok MA; Lind GE; Nesbakken A; Skotheim RI; Lothe RA
Gut; 2012 Nov; 61(11):1560-7. PubMed ID: 22213796
[TBL] [Abstract][Full Text] [Related]
23. A two-microRNA-based signature predicts first-line chemotherapy outcomes in advanced colorectal cancer patients.
Lu JH; Zuo ZX; Wang W; Zhao Q; Qiu MZ; Luo HY; Chen ZH; Mo HY; Wang F; Yang DD; Wang Y; Wei XL; Wu QN; Ju HQ; Xu RH; Zeng ZL
Cell Death Discov; 2018; 4():116. PubMed ID: 30588338
[TBL] [Abstract][Full Text] [Related]
24. Prognostic role of serum AZGP1, PEDF and PRDX2 in colorectal cancer patients.
Ji D; Li M; Zhan T; Yao Y; Shen J; Tian H; Zhang Z; Gu J
Carcinogenesis; 2013 Jun; 34(6):1265-72. PubMed ID: 23393224
[TBL] [Abstract][Full Text] [Related]
25. A Seven-microRNA Expression Signature Predicts Survival in Hepatocellular Carcinoma.
Zhang J; Chong CC; Chen GG; Lai PB
PLoS One; 2015; 10(6):e0128628. PubMed ID: 26046780
[TBL] [Abstract][Full Text] [Related]
26. DNA Repair-Related Gene Signature in Predicting Prognosis of Colorectal Cancer Patients.
Lv MY; Wang W; Zhong ME; Cai D; Fan D; Li CH; Kou WB; Huang ZP; Duan X; Hu C; Zhu Q; He X; Gao F
Front Genet; 2022; 13():872238. PubMed ID: 35495147
[No Abstract] [Full Text] [Related]
27. Down-regulation of Barx2 predicts poor survival in colorectal cancer.
Mi Y; Zhao S; Zhang W; Zhang D; Weng J; Huang K; Sun H; Tang H; Zhang X; Sun X; Peng Z; Wen Y
Biochem Biophys Res Commun; 2016 Sep; 478(1):67-73. PubMed ID: 27453340
[TBL] [Abstract][Full Text] [Related]
28. A prognostic classifier consisting of 17 circulating cytokines is a novel predictor of overall survival for metastatic colorectal cancer patients.
Chen ZY; He WZ; Peng LX; Jia WH; Guo RP; Xia LP; Qian CN
Int J Cancer; 2015 Feb; 136(3):584-92. PubMed ID: 24916890
[TBL] [Abstract][Full Text] [Related]
29. Transcriptomic data analysis coupled with copy number aberrations reveals a blood-based 17-gene signature for diagnosis and prognosis of patients with colorectal cancer.
Kaya IH; Al-Harazi O; Colak D
Front Genet; 2022; 13():1031086. PubMed ID: 36685857
[No Abstract] [Full Text] [Related]
30. ColoFinder: a prognostic 9-gene signature improves prognosis for 871 stage II and III colorectal cancer patients.
Shi M; He J
PeerJ; 2016; 4():e1804. PubMed ID: 26989635
[TBL] [Abstract][Full Text] [Related]
31. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
[TBL] [Abstract][Full Text] [Related]
32. Identification and validation of a blood-based 18-gene expression signature in colorectal cancer.
Xu Y; Xu Q; Yang L; Ye X; Liu F; Wu F; Ni S; Tan C; Cai G; Meng X; Cai S; Du X
Clin Cancer Res; 2013 Jun; 19(11):3039-49. PubMed ID: 23536436
[TBL] [Abstract][Full Text] [Related]
33. High expression of Beclin-1 predicts favorable prognosis for patients with colorectal cancer.
Yang Z; Ghoorun RA; Fan X; Wu P; Bai Y; Li J; Chen H; Wang L; Wang J
Clin Res Hepatol Gastroenterol; 2015 Feb; 39(1):98-106. PubMed ID: 25130795
[TBL] [Abstract][Full Text] [Related]
34. A robust gene expression-based prognostic risk score predicts overall survival of lung adenocarcinoma patients.
Chen EG; Wang P; Lou H; Wang Y; Yan H; Bi L; Liu L; Li B; Snijders AM; Mao JH; Hang B
Oncotarget; 2018 Jan; 9(6):6862-6871. PubMed ID: 29467935
[TBL] [Abstract][Full Text] [Related]
35. Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer.
Li Y; Liang L; Dai W; Cai G; Xu Y; Li X; Li Q; Cai S
Mol Cancer; 2016 Aug; 15(1):55. PubMed ID: 27552968
[TBL] [Abstract][Full Text] [Related]
36. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer.
Hur K; Toiyama Y; Schetter AJ; Okugawa Y; Harris CC; Boland CR; Goel A
J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25663689
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA 211 expression is upregulated and associated with poor prognosis in colorectal cancer: a case-control study.
Sümbül AT; Göğebakan B; Bayram S; Batmacı CY; Öztuzcu S
Tumour Biol; 2015 Dec; 36(12):9703-9. PubMed ID: 26152286
[TBL] [Abstract][Full Text] [Related]
38. Establishment and external verification of an oxidative stress-related gene signature to predict clinical outcomes and therapeutic responses of colorectal cancer.
Cao S; Chen C; Gu D; Wang Z; Xu G
Front Pharmacol; 2022; 13():991881. PubMed ID: 36860211
[No Abstract] [Full Text] [Related]
39. Overexpression of Wnt7α protein predicts poor survival in patients with colorectal carcinoma.
Wang Y; Wei J; Zhang S; Li G; Zhang T; Yu X; Chen H; Liu M
Tumour Biol; 2015 Nov; 36(11):8781-7. PubMed ID: 26055144
[TBL] [Abstract][Full Text] [Related]
40. Derivation and Clinical Validation of a Redox-Driven Prognostic Signature for Colorectal Cancer.
Dang Q; Liu Z; Hu S; Chen Z; Meng L; Hu J; Wang G; Yuan W; Han X; Li L; Sun Z
Front Oncol; 2021; 11():743703. PubMed ID: 34778061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
